Erratum: The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

The publisher regrets an error in the caption for Figure 4C in the above article published in Seminars in Thrombosis and Hemostasis, Volume 33, Number 7, 2007, page 648 (DOI: 10.1055/s-2007-991531). The credit line was not included for Figure 4C. The corrected caption appears below.

Fig. 4 The effect of enoxaparin and NA-LMWH on (A) tumor cell–induced thrombocytopenia and (B, C) experimental lung metastasis. Results show that NA-LMWH is not able to blunt tumor cell–induced coagulation activation compared with enoxaparin but exhibits significant antimetastatic effect similar to that of enoxaparin. (Figure 4C reprinted with permission from Mousa SA, Linhardt R, Francis JL, Amirkhosravi A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost 2006;96:816–821. © Thieme. All rights reserved.)

Publication History

Article published online:
10 October 2022